Acquire the license to the best health content in the world
Contact Us

Clinical Trials Update: Sept. 30, 2002

Chronic Pain Drugs Newly Approved by the FDA Hepsera Fluzone

Here are the latest clinical trials, courtesy of CenterWatch.

Chronic Pain

A Randomized, Double-Blind, Placebo-Controlled Study of Intrathecal Ziconotide in Adults with Severe Chronic Pain. Purpose of the study is to understand the effects of intrathecal ziconotide (an experimental pain medication) when the dose is slowly increased over a 3-week period. Sites throughout the USA.

More Information

Please see http://www.centerwatch.com/patient/studies/cat45.html.

-----

Drugs Newly Approved by the FDA

Hepsera (adefovir dipivoxil)

For the treatment of chronic hepatitis B in adults with evidence of active viral replication; Gilead Sciences; Approved September 2002.

More Information

Please see http://www.centerwatch.com/patient/drugs/dru797.html.

-----

Fluzone Preservative-free

Preservative free, pediatric dose, influenza virus vaccine for the immunization of infants; Aventis Pasteur; Approved September 2002.

More Information

http://www.centerwatch.com/patient/drugs/dru798.html.

-----

Copyright @#169;2002 Centerwatch. All rights reserved.

Consumer News